Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

High Content Screening Market 2017 by Product, Application, End User - Global Forecast to 2022 - Research and Markets

Research and Markets
Posted on: 20 Apr 17

Research and Markets has announced the addition of the "High Content Screening Market by Product, Application, End User - Global Forecast to 2022" report to their offering.

The global high-content screening (HCS) market is projected to reach USD 909.0 million by 2022 at a CAGR of 10.3% during the forecast period.

The factors expected to drive the growth of the market are cost containment in pharmaceutical R&D, increasing funding for cellular research, and technological advancements in HCS solutions during the forecast period. The rapid growth in developing countries across APAC is also expected to provide an opportunity for revenue generation in the market. However, the high cost of HCS instruments and the dearth of knowledgeable and skilled personnel for the operation of the instruments are expected to restrain the market growth to a certain extent.

The HCS instruments market accounted for the largest share of HCS market primarily attributed to advances in instrumentation and automation techniques and high prices of the HCS instruments. The software segment is expected to register the highest growth during the forecast period. The growth of this market is attributed to the technological advancements in image acquisition, data analysis, and storage capabilities and the need to obtain information on changes in cell morphology through high-quality images.

North America is the largest market for high-content screening, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Global High-Content Screening Market, By Product

8 Global High-Content Screening Market, By Application

9 Global High-Content Screening Market, By End User

10 High-Content Screening Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biotek Instruments, Inc.
  • Danaher Corporation
  • GE Healthcare
  • Merck Millipore
  • Perkinelmer, Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Yokogawa Electric Corporation

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/04/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.